Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension.

× No keyword cloud information.

33 in total

Review 1. Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.

Authors: Rongras Damrongwatanasuk; Michael G Fradley
Journal: Curr Treat Options Cardiovasc Med Date: 2017-04

Review 2. Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease.

Authors: Arvind K Pandey; Eric K Singhi; Juan Pablo Arroyo; Talat Alp Ikizler; Edward R Gould; Jonathan Brown; Joshua A Beckman; David G Harrison; Javid Moslehi
Journal: Hypertension Date: 2017-12-26 Impact factor: 10.190

Review 3. Cardiovascular toxicity of anti-angiogenic drugs.

Authors: Gaetan des Guetz; Bernard Uzzan; Kader Chouahnia; Jean-François Morère
Journal: Target Oncol Date: 2011-11-25 Impact factor: 4.493

4. Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab.

Authors: Elisabeth Bumes; Sarah Rzonsa; Markus Hutterer; Martin Proescholdt; Ulrich Bogdahn; Markus J Riemenschneider; Martin Uhl; Christina Wendl; Peter Hau
Journal: J Neurooncol Date: 2015-12-31 Impact factor: 4.130

Review 5. Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives.

Authors: Steven M Bair; Toni K Choueiri; Javid Moslehi
Journal: Trends Cardiovasc Med Date: 2013-01-02 Impact factor: 6.677

Review 6. Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy.

Authors: Devron R Shah; Rashmi R Shah; Joel Morganroth
Journal: Drug Saf Date: 2013-06 Impact factor: 5.606

7. Sorafenib cardiotoxicity increases mortality after myocardial infarction.

Authors: Jason M Duran; Catherine A Makarewich; Danielle Trappanese; Polina Gross; Sharmeen Husain; Jonathan Dunn; Hind Lal; Thomas E Sharp; Timothy Starosta; Ronald J Vagnozzi; Remus M Berretta; Mary Barbe; Daohai Yu; Erhe Gao; Hajime Kubo; Thomas Force; Steven R Houser
Journal: Circ Res Date: 2014-04-09 Impact factor: 17.367

8. Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options.

Authors: Bryan J Brinda; Federico Viganego; Teresa Vo; Dawn Dolan; Michael G Fradley
Journal: Curr Treat Options Cardiovasc Med Date: 2016-05

Review 9. Emerging paradigms in cardiomyopathies associated with cancer therapies.

Authors: Bonnie Ky; Pimprapa Vejpongsa; Edward T H Yeh; Thomas Force; Javid J Moslehi
Journal: Circ Res Date: 2013-08-30 Impact factor: 17.367

Review 10. Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Authors: Mizuki Nishino; Hiroto Hatabu; Lynette M Sholl; Nikhil H Ramaiya
Journal: Radiographics Date: 2017 Sep-Oct Impact factor: 5.333